iRhythm Holdings, Inc. (IRTC) intrinsic value & 10-year financials

iRhythm Holdings, Inc. (IRTC) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 31.4% a year to $747.1M, with an average return on invested capital of -90.1%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$108.66
Market cap
$3.5B
Revenue (FY2025)
$747.1M
Revenue growth (10-yr CAGR)
31.4%
ROIC (10-yr avg)
-90.1%
Free cash flow (FY2025)
$34.5M

IRTC 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $747.1M -$44.6M -$1.39 $34.5M -7.7% 42.2%
FY2024 $591.8M -$113.3M -$3.63 -$30.6M -19.5% -669.6%
FY2023 $492.7M -$123.4M -$4.04 -$90.5M -25.4% -44.1%
FY2022 $410.9M -$116.2M -$3.88 -$52.8M -27.7% -43.3%
FY2021 $322.8M -$101.4M -$3.46 -$65.8M -31.0% -33.2%
FY2020 $265.2M -$43.8M -$1.58 -$27.3M -16.5% -14.8%
FY2019 $214.6M -$54.6M -$2.16 -$42.3M -25.5% -36.1%
FY2018 $147.3M -$48.3M — -$34.2M -29.6% -50.1%
FY2017 $98.5M -$29.4M — -$18.5M -27.7% -30.6%
FY2016 $64.1M -$20.9M — -$19.4M -24.3% -21.3%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

iRhythm Holdings, Inc. is a consistent compounder, expanding top-line revenue at 31.4% annually over the past decade.

iRhythm Holdings, Inc. has historically struggled to out-earn its cost of capital, averaging just -23.8% ROIC.

iRhythm Holdings, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, iRhythm Holdings, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-46.17 per share.

IRTC stock: frequently asked questions

What is the intrinsic value of iRhythm Holdings, Inc. (IRTC) stock?

Graham's formula only works with positive earnings. iRhythm Holdings, Inc. reported diluted EPS of -$1.39 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has iRhythm Holdings, Inc. grown?

Revenue went from $64.1M in fiscal 2016 to $747.1M in fiscal 2025, a compound annual growth rate of 31.4%. Net income was -$44.6M in fiscal 2025.

Does iRhythm Holdings, Inc. generate free cash flow?

iRhythm Holdings, Inc. generated $34.5M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 1 of the last 10 reported years.

What is IRTC's return on invested capital?

Average ROIC over the last 10 fiscal years was -90.1%, and average return on equity was -44.9%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this IRTC data come from?

From iRhythm Holdings, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 6, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks